Terms: = Ovarian cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Staging
6 results:
1. Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.
Li X; Wang J; Wu W; Gao H; Liu N; Zhan G; Li L; Han L; Guo X
FEBS J; 2020 Dec; 287(23):5218-5235. PubMed ID: 32239647
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic role of excision repair cross complementing-1 and topoisomerase-1 expression in epithelial ovarian cancer.
Liu SC; Lin H; Huang CC; Chang Chien CC; Tsai CC; Ou YC; Fu HC; Liu JM; Ma YY
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):213-9. PubMed ID: 27125404
[TBL] [Abstract] [Full Text] [Related]
3. FISH analysis of BRCA1 copy number in paraffin-embedded ovarian cancer tissue samples.
Kato H; Arakawa A; Suzumori K; Kataoka N; Young SR
Exp Mol Pathol; 2004 Apr; 76(2):138-42. PubMed ID: 15010292
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
[TBL] [Abstract] [Full Text] [Related]
5. Long-term results of therapy for stage C neuroblastoma.
Halperin EC
J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
[TBL] [Abstract] [Full Text] [Related]
6. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract] [Full Text] [Related]
